Published in Blood Weekly, May 5th, 1997
The company has been developing ThromboSol storage solution for the sustained preservation of transfusable platelets. The issued U.S. patent covers the preservation of platelets at temperatures of 8(degree)C and below using compounds that effectively inhibit normal platelet activity during storage.
Additional patent applications relating to the ThromboSol process are pending with the U.S. and foreign patent authorities. The development of ThromboSol has been funded in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.